Voloridge Investment Management, LLC Esperion Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $742,690 - $3.71 Million	-508,692 Reduced 74.86%	170,838 $271,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $3.46 Million - $5.78 Million	679,530 New	679,530 $4.23 Million
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $1.91 Million - $2.67 Million	-400,112 Reduced 74.39%	137,744 $876,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $347,957 - $579,235	-104,179 Reduced 16.23%	537,856 $2.5 Million
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $1.85 Million - $4.59 Million	385,274 Added 150.05%	642,035 $3.21 Million
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $2.18 Million - $4.1 Million	191,967 Added 296.27%	256,761 $3.09 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $1.26 Million - $1.86 Million	64,794 New	64,794 $1.37 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $1.25 Million - $1.83 Million	-49,643 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $1.2 Million - $1.78 Million	49,643 New	49,643 $1.29 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $176,741 - $475,603	-6,441 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $228,011 - $385,300	6,441 New	6,441 $384,000
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $192,032 - $264,789	-5,571 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $223,397 - $291,530	5,571 New	5,571 $259,000
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $4.46 Million - $5.46 Million	-67,666 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$43.47 - $67.43 $1.04 Million - $1.61 Million	-23,814 Reduced 26.03%	67,666 $4.46 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $4.01 Million - $4.83 Million	91,480	91,480 $4.59 Million

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account